Entresto (Sacubitril / Valsartan) for the Treatment of Heart Failure
NYHA functional classifications are based on the extent of heart failure in heart disease patients. Credit: Novartis.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more